SUMMARY Aspirated fasting gastric juice from patients with lesions of the gastrointestinal tract and from healthy controls was analysed for nitrite before and after (30, 90, and 240 min) oral administration of 200 mg nitrate. Wilcoxon's rank-sum tests showed no significant differences in fasting gastric juice nitrite concentrations between healthy controls and patients after proximal gastral vagotomy or with gastric/duodenal ulcer (median .0 7 ppm NO2-) and only moderate increases after nitrate administration. Chronic atrophic gastritis patients and patients with Billroth I or II gastric resections showed median concentrations of 2 ppm NO2-which increased to 20 ppm (up to 200 ppm in one Billroth II patient) after administration of nitrate. Endogenous formation of N-nitrosoproline using the NPRO-test was determined in two groups with low (healthy control and proximal gastral vagotomy patients) and high (Billroth I and II patients) gastric nitrite concentrations. After 12 h fasting, 200 mg nitrate was orally administered, followed 30 min later by 500 mg L-proline. Endogenously formed N-nitrosoproline which is quantitatively excreted in urine was determined in urine over the following 24 hours. In over 80% of the urine samples collected from Billroth I and II patients no detectable NPRO was found whilst in over 85% of the healthy controls and proximal gastral vagotomy patients up to 33.5 jig NPRO was detected. In vitro nitrosation kinetics showed that at gastric pH>4 present in both, patients with Billroth I and II resections and with chronic atrophic gastritis, nitrosation of proline does not occur. As alternative chemical probes for quantifying potential endogenous nitrosation in hypoacidic patients the methyl and ethyl esters of proline were investigated. In vivo nitrosation of these two new probes was established in animal experiments using rats and was shown to occur in vitro at pH 4-5. During incubation in human gastric juice, however, almost 30% ester cleavage by non-specific gastric esterases occurred within the first five minutes, thus further limiting the use of these compounds in determining endogenous nitrosation in hypoacidic patients.
Nitrite concentrations in the gastric fluid have been shown to be (directly) correlated with intragastric pH." Under conditions of hypochlorhydria, bacterial contamination of gastric juice is common and nitrate reducing microorganisms are regularly found. ' 34 The presence of raised nitrite concentrations is considered to favour the intragastric formation of N-nitroso compounds under such conditions.
It has been reported that intragastric concentrations of N-nitroso-compounds are enhanced in the anacidic pH -for example, in patients with Billroth II gastric resection'5 and that a positive correlation between pH and N-nitroso compound concentration was observed." ' 1 Other authors have, however, not found such a correlation.'7 Analytical problems to be faced with determination of total N-nitrosocompounds in gastric juice may, at least in part, be responsible for these contradictory findings. They have been adequately reviewed by Pignatelli et al. '6 In our earlier experiments we had analysed gastric juice before and after gavage of 200 mg nitrate to investigate how various disorders of the upper gastrointestinal tract influence the intragastric concentration of nitrite.`6 Three patient groups were found to have high nitrite formation rates in the gastric juice: gastric resection after Billroth I (BI) or Billroth II (BIT) and chronic atrophic gastritis (CAG). These patient groups have now been increased to 12 subjects, and furthermore we have investigated the potential of endogenous formation of N-nitroso compounds using proline as an indicator and monitoring the urinary excretion of nitrosoproline (NPRO). This N-nitroso compound is neither mutagenic nor carcinogenic.9 2 For the NPRO-test, patients were selected from the BI, BIT, and PGV-groups. As CAG patients were not available within this period we restricted our investigations to BI and BIT (high nitrite groups) and PGV (low nitrite group).
The patients and healthy controls participating in this study had been given detailed information on the eXperimental procedure, its aim and its risks and had given their oral consent. The bottles were stored at 5oC until analysis. Food ingestion was recorded on the day of the experiment and on the day before. Smoked or cured products were not allowed to minimise intake of preformed NPRO.29 NPRO 
DETERMINATION
The total volume of the 24 h urine was measured.
Aliquots of 15 ml were taken for NPRO determination (double). After the addition of 500 ig NPIC as an internal standard, the sample was deproteinised with 1 ml each of potassium hexacyanoferrate II (106 g K4 Fe(CN)6l water) and zinc sulphate (220 g ZnSO4/l acetic acid, 3%). After filtration through a glass fibre filter, the filtrate was saturated with 9 g ammonium sulphate. Sulphuric acid (1 ml, 50%) was added and the sample was transferred to a column of 13 g silica gel (ExtrelutR, Merck, Darmstadt, FRG) over 2 g anhydrous sodium sulphate. After 20 min equilibration the column was eluted with 60 ml ethyl acetate. The eluate was evaporated in a rotary evaporator at 50°C to a final volume of about 1 ml. The concentrate was transferred to a 20 ml reaction vial and an excess (normally 2 ml) of distilled ethereal diazomethane was added. After 15 min standing at room temperature the volume was reduced to 1 ml by a gentle stream of nitrogen.
GC-ANALYSIS
Glass column:
1 mx2 mm, packed with 3% Carbowax 20 M, TPA on Volaspher (100-120 mesh) Carrier gas:
helium, 30 ml/min Oven temperature: 130°C (4 min) and programmed to 210°C at 4°/min Detector:
TEA, model 502 (Thermo Electron, Waltham, MA, USA) Recovery of NPRO was 79% (SD=6-8, n=6) and of the internal standard NPIC 92% (SD=6 8, n=6); detection limit of NPRO was 0.5 ppb.
IN VITRO NITROSATION OF PROLINE AND PROLINE ESTERS
Solutions of proline or proline ester and nitrite (50 mM each) were incubated at 37°C for 60 min in citrate buffer (20 ml, pH 2-6). Yields of N-nitroso products were determined spectrometrically at 320-400 nm against solvent blanks (Lambda 5, recording spectrophotometer, Perkin Elmer, Uberlingen, FRG). 
